DEXAMFETAMINE

Clinical Indication

Excessive sleepiness caused by narcolepsy

Comments

SCA

Date of classification

March 2022

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.